Search

everythinglearnresearchcommunity

for

Search:↓

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Upadacitinib improved multiple immune-related conditions in one patient.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Curcuma aeruginosa extract lotion significantly reduces underarm hair growth.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Leflunomide is more likely to help treat alopecia areata than cause it.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Geranium sibiricum may help manage diabetic complications by inhibiting a key enzyme.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

AnnoPharma effectively identifies substances causing adverse drug reactions in medical abstracts.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Curcuma aeruginosa extract lotion effectively reduces underarm hair growth.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.